Unique-Speciality Dignostic Laboratory Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 24 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -327.86%
- Ebitda -145.75%
- Net Worth -16.87%
- Total Assets -23.92%
About Unique-Speciality Dignostic Laboratory
Unique-Speciality Dignostic Laboratory Private Limited (UDLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 2001 and has a history of 24 years. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Thigale and Rupali Thigale serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85195MH2001PTC130454
- Company No.
130454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2001
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Unique-Speciality Dignostic Laboratory?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Thigale  | Director | 15-Jan-2001 | Current |
| Rupali Thigale | Director | 15-Jan-2001 | Current |
Financial Performance of Unique-Speciality Dignostic Laboratory.
Unique-Speciality Dignostic Laboratory Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 327.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unique-Speciality Dignostic Laboratory?
In 2021, Unique-Speciality Dignostic Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unique-Speciality Dignostic Laboratory?
Unlock and access historical data on people associated with Unique-Speciality Dignostic Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unique-Speciality Dignostic Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unique-Speciality Dignostic Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
